<DOC>
	<DOCNO>NCT00902265</DOCNO>
	<brief_summary>Documentation efficacy safety desmopressin ( Nocturin® ) 0.1 mg tablet . Observation patient benign prostate syndrome , nocturia associate nocturnal polyuria treat desmopressin ( Nocturin® ) 0.1 mg tablet focus number nocturnal void , ratio night/24-h urine volume ( % ) , duration first undisturbed sleep period quality life .</brief_summary>
	<brief_title>Efficacy Safety Desmopressin ( Nocturin® ) 0.1 mg Tablets Treatment Nocturia Participants With Benign Prostate Syndrome ( BPS )</brief_title>
	<detailed_description />
	<mesh_term>Lower Urinary Tract Symptoms</mesh_term>
	<mesh_term>Nocturia</mesh_term>
	<mesh_term>Polyuria</mesh_term>
	<mesh_term>Deamino Arginine Vasopressin</mesh_term>
	<criteria>Therapeutic need accord Summary Product Characteristics Written inform consent Contraindications accord Summary Product Characteristics</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>